Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies
Phase: PHASE1
Conditions: Alcohol Abuse, Alcohol Use Disorder, Alcohol Abuse, Episodic
Sponsor: Kent State University

Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies 
NCT Number: 04286867 
Date: 5/11/2023 

CONTINUING/ANNUAL REVIEW FORM 
IRB LOG NUMBER ________18-199 
Page 1 of 7 
Questions? Email Researchcompliance@kent.edu 
Revision 6.5 
CONTINUING/ANNUAL REVIEW FORM 
INSTRUCTIONS for INVESTIGATORS: 
IRB Office use only 
Date Received 
4/27/21 
Name of Discipline 
Specific Reviewer 
Agenda Date 
August 2021 
Date of IRB 
Determination email 
to Investigator 
IRB ACTION 
Date 
 Approved (CR) 
5/23/21-5/22/22 (2) 
 Approved (AR) 
 Other 
STAMP CONSENT 
EXTERNAL FUNDING 
 Yes 
 No 
 Yes 
 No 
______________________________________ 
Signature of Chair, IRB     
 Date 
______________________________________ 
Signature of IRB Administrator 
 Date 
or Designee 
1. Level II research: complete this form to request transfer to a three-
year approval interval. At the IRB’s discretion, certain level II studies
may not be transferred to three-year intervals; examples include:
a.
Level III projects 
b.
A grant or contract requires annual review 
c.
DOD and DOJ funded studies
d.
FDA regulated research 
e.
NIH funded clinical trials 
f.
Longitudinal studies lasting more than three years 
g.
New risks have been identified 
h.
Adverse events or an unanticipated problem involving
risk to subjects 
2. Level III research: must be reviewed at the interval determined by 
the IRB, at least annually. Investigators are responsible for fulfilling 
requirements associated with continuing review in time for the IRB 
to carry out review prior to the expiration date of the current IRB 
approval. 
3. Submit this completed document via email attachment to 
RESEARCHCOMPLIANCE@kent.edu. Be sure to include “clean”, 
unstamped copies of the consent form, scripts, etc… 
To submit the form with a typed signature, the form must be 
submitted from the Investigator’s @kent.edu email account. If 
completed form is signed and then scanned as a PDF attachment, the 
@kent.edu email requirement does not apply. 
TO COMPLETE THIS FORM: SINGLE LEFT-CLICK TO COMPLETE TEXT FIELDS. TO CHECK A BOX, DOUBLE LEFT-
CLICK ON THE BOX, THEN CLICK “CHECKED”. CLICK OK. 
Can your study be closed? 
If all research-related interventions and/or interactions with participants have been 
completed and data is de-identified, do not submit this form - you must file a closeout form 
Section 1 - KSU Investigator Information 
Last Name: Lechner  First Name: Ahmad 
IRB Log Number: 18-199 
Title of Study (should match Human Subjects Research Application): 
Examining alcohol consumption, perceptions, and user experience of alcohol moderation strategies. 
Section 2 - RESEARCH STATUS 
a.
Indicate the status of the research:
Research participants have NOT been enrolled (or participant records, specimens, etc. 

CONTINUING/ANNUAL REVIEW FORM
IRB LOG NUMBER ________18-199
Page 2 of 7 
Questions? Email Researchcompliance@kent.edu
Revision 6.5 
obtained).
Explain:
     
Research participants HAVE been enrolled (or participant records, specimens, etc. obtained)
b. If participants have been enrolled, 
Recruitment is ongoing
Recruitment has been completed Æ Check all that apply
1. Interactions and/or interventions are continuing.
2. All research related interaction and intervention have been completed or the research did 
not involve interaction/interventions.
3. Data contains identifiers.
4. Data is de-identified.                                 
If you selected options 2 and 4 you need to submit a closeout form. Do not 
submit this form.
Section 3  INVESTIGATOR INFORMATION
CO-INVESTIGATOR(S) & KEY PERSONNEL (Kent State University personnel only)
a. Are key personnel being added to the study? 
Yes 
No
If Yes Æ Please List:      
b. Are key personnel being removed from the study? 
Yes
No
If Yes ÆPlease list:      
“Key personnel” are defined as individuals who participate in the design, conduct, or reporting of human 
subjects research.  At a minimum, include individuals, who recruit participants, obtain consent or, who collect 
study data. You must submit CITI certificates for new personnel.
Are the human subjects protection online training requirements (CITI) current for all Kent 
State investigator(s) and key personnel?  
Yes 
No
Section 4 - EXTERNAL CO-INVESTIGATOR(S) & KEY PERSONNEL (non-Kent State University personnel only)
Are there any changes in external study personnel?
 Yes ÆComplete Appendix B
No

CONTINUING/ANNUAL REVIEW FORM 
IRB LOG NUMBER ________18-199 
Page 3 of 7 
Questions? Email Researchcompliance@kent.edu 
Revision 6.5 
Section 5 - FINANCIAL CONFLICT OF INTEREST 
a. Does any Kent State University investigator (including principal or co-investigator),
key personnel, or their immediate family members have a financial interest (including
salary or other payments for services, equity interests, or intellectual property rights)
that would reasonably appear to be affected by the research, or a financial interest in
any entity whose financial interest would reasonably appear to be affected by the
research?
 Yes 
 No 
Section 6 - FUNDING OR OTHER SUPPORT 
If the research is externally funded and/or involves a subcontract to or from another entity, an IRB 
Authorization Agreement may be required.  Contact the Office of Research Compliance for more information. 
a. What is the current funding status of the research?
  None 
  Funded 
If funded Æ Specify sponsor  
If fundedÆ Does the sponsor require annual review? 
  Yes 
  No 
b. Is any support other than monetary (e.g., drugs, equipment, etc.) being provided
for the study?
  Yes 
  No 
If Yes Æ Specify support and 
provider: 

CONTINUING/ANNUAL REVIEW FORM 
IRB LOG NUMBER ________18-199 
Page 4 of 7 
Questions? Email Researchcompliance@kent.edu 
Revision 6.5 
Section 7 - RESEARCH SUMMARY 
Summarize the research made using non-technical language that can be readily understood by someone 
outside the discipline. Explain briefly the research design, procedures used, risks and anticipated benefits, 
and the importance of the knowledge that may be expected to result. Use complete sentences (limit 500 
words). 
Heavy episodic drinking is related to a range of unfavorable outcomes and represents a significant public 
health problem. Despite experiencing significant negative consequences, the majority of problem drinkers 
will never seek treatment from a direct care provider (SAMHSA, 2015). Mobile technology has the potential 
to transform how alcohol interventions are delivered by providing a more direct platform to promote 
behavior change. Indeed, mobile technologies have demonstrated utility in providing treatment 
information for a wide-range of behaviors for which individuals often hesitate to seek professional help, 
including smoking cessation, sexual health, weight management, and anxiety (Cohn, Hunter-Reel, 
Hagman, & Mitchell, 2011). Moreover, recent research suggests that tools aimed at reducing irresponsible 
drinking behaviors often fail because they do not account for barriers to treatment implementation caused 
by the intoxicating effects of alcohol. Alcohol directly affects several underlying neurocognitive 
mechanisms necessary for adhering to drinking limits (Day et al., 2015; Guillot, Fanning, Bullock, 
McCloskey, & Berman, 2010; Kahler et al., 2014; Lechner, 2016). Specifically, alcohol affects the ability to 
maintain focus on previously defined goals (e.g. I will only have 2 drinks), and to weigh those goals against 
competing acute reinforcers (pleasurable effects of alcohol) (Houben, Wiers, & Jansen, 2011). Therefore, 
two major barriers to changing problematic patterns of alcohol use include (1) willingness to seek 
professional help despite motivation to change, (2) difficulty adhering to pre-defined drinking limits caused 
by alcohol’s intoxicating effects. The current application proposes to test a mobile application with 
potential to address both of these barriers. First, the mobile application provides an active self-help based 
platform for moderating alcohol use that is accessible without seeking assistance from a health-care 
provider. Second, the application provides guidance on moderating alcohol use in real time based on 
individual users pre-defined drinking limits, which helps reduce demands on the neurocognitive 
mechanisms that are diminished following alcohol consumption. Specifically, the application utilizes an 
algebraic formula to proactively pace a user’s alcohol consumption over time (provides a visual cue of how 
much of their current beverage should be remaining, as well as the time remaining until they can start their 
next drink) based on their predefined drinking limits, as well as individual factors including weight, sex, and 
other variables affecting the metabolism of alcohol. 
Section 8 - RECRUITMENT & INFORMED CONSENT PROCESS 
a. Were recruitment materials used to enroll
participants?
  Yes    
  No   
If Yes Æ Are recruitment materials still being 
used? 
  Yes Æ Provide copies of the current recruitment 
materials (ads, radio/TV scripts, internet 
solicitations, etc.). 
  No 
b. How was/is informed consent or assent obtained?  Check all that apply. Provide “clean” copies of all
current documents.
Assent – Form  
Parental Permission – Form  
Assent – Verbal Script 
Parental Permission – Verbal Script 

CONTINUING/ANNUAL REVIEW FORM 
IRB LOG NUMBER ________18-199 
Page 5 of 7 
Questions? Email Researchcompliance@kent.edu 
Revision 6.5 
Informed Consent – Form 
Translated Consent/Assent – Form(s)  
Informed Consent – Verbal Script 
Waiver or Alteration of Consent Process 
Informed Consent – Addendum  
Waiver of Consent Documentation 
c. Is deception of participants part of the
research?
  Yes Æ Provide copy of current debriefing script or 
other information sheet(s) used to inform 
participants. 
  No 
Section 9 - RESEARCH PROGRESS 
A. Summarize the progress of the research, including any interim findings.
To date, we have consented 34 participants. Recruitment was significantly slowed due to COVID-19
study suspensions and time needed to ensure study procedures conformed to research activity 
requirements introduced due to the COVID-19 pandemic.   
B. For multi-site studies, summarize the overall progress of the research. Attach a copy of the most
recent multi-site study report, if any.
N/A 
C. Summarize any IRB-approved amendments or changes made to the research since last IRB
review (initial or continuing). If IRB approval was not obtained for changes, provide an 
explanation.
N/A
Approved Amendment 3/4/21
We requested approval to screen potential participants via electronic survey. No additional assessments
were added, we modified our phone screen to screen participants via Qualtrics survey platform. 
Approved Amendment 1/13/21 
We requested changes to our recruitment materials to include Facebook/Instagram advertising. This 
change was done to improve recruitment efforts following COVID-19 lockdown restrictions.   
D. Summarize recent literature or other new information relevant to the research, if any, since last
IRB review (initial or continuing).
N/A 
E. Discuss significant new findings (e.g., affecting risks, benefits, or alternatives), if any, that could
affect participants’ willingness to continue in the research and how participants have been or
will be informed.
N/A 
F. Indicate projected or actual completion date (month and year):
Indicate “ongoing” for repository research or program protocols
5/1/2022 

CONTINUING/ANNUAL REVIEW FORM 
IRB LOG NUMBER ________18-199 
Page 6 of 7 
Questions? Email Researchcompliance@kent.edu 
Revision 6.5 
Section 10- NUMBER OF PARTICIPANTS 
The number of participants is defined as the number of individuals who agreed to participate (i.e., those who 
provided consent or whose records were accessed, etc.) even if all do not prove eligible or complete the study. 
The total number of research participants may be increased only with prior IRB approval.  
a. Is this a multi-site study?
  Yes  Æ Indicate the total number of 
participants to be enrolled across all sites: 
  No 
b. For research approved by an Kent State University IRB, provide:
1) IRB approved number of participants (or records, specimens,
etc.):
64 
2) Total number of participants enrolled in the research to date:
34 
3) Number of participants enrolled since last IRB review (initial or
continuing):
4 
c. If the actual total enrollment to date is significantly different (over or under) from IRB approved
number, provide an explanation:
Recruitment is lower than originally projected due to COVID-19 related study suspensions.
d. Are you requesting an increase in the total number of participants?
  Yes Æ answer a & b 
  No 
a. What is the requested number of participants (or records,
specimens) to be added?
b. Provide rationale for adding participants:
Section 11 - PARTICIPANT COMPLAINTS & VOLUNTARY WITHDRAWALS 
a. Have any participants made complaints about the research since the last IRB review?
  Yes    
  No 
If Yes Æ List and describe each complaint and any actions taken to resolve the complaint(s). 
b. Have any participants voluntarily withdrawn from the research since last IRB review?
Do not include individuals whose participation was discontinued by the investigator or 
sponsor because of unanticipated problems, study completion, etc. 
  Yes    
  No 
If Yes Æ List and describe each withdrawal and any actions taken (e.g., changes to the research or 
consent process) in response to the withdrawal(s). 
Section 12 - RISK ASSESSMENT 
a. Since the last IRB review (initial or continuing), did any unanticipated problems involving risks to
subjects or others or adverse events occurred in research?

CONTINUING/ANNUAL REVIEW FORM
IRB LOG NUMBER ________18-199
Page 7 of 7 
Questions? Email Researchcompliance@kent.edu
Revision 6.5 
Yes Æ Complete Appendix R
No
b. Is the research subject to Data and Safety Monitoring Board (DSMB) or
other similar committee/group review?
  Yes Æ Provide a copy 
of the most current 
report.
  No
c. Provide an assessment of the risks and potential benefits based on study results since last IRB review.
The risks and potential benefits have not changed since the last IRB review.
d.
Summarize recent literature or other new information relevant to the research, if any, since
last IRB review (initial or continuing).
N/A
e. Discuss significant new findings (e.g., affecting risks, benefits, or alternatives), if any, that
could affect participants’ willingness to continue in the research and how participants have
been or will be informed.
N/A
Section 13 - PRINCIPAL INVESTIGATOR’S ASSURANCE 
I agree to follow all applicable federal regulations, guidance, state and local laws, and university policies 
related to the protection of human subjects in research, as well as professional practice standards and 
generally accepted good research practices for investigators.
I verify that the information provided in this Continuing/Annual Review form is accurate and complete.  
4/27/2021
Signature of Principal Investigator
Date
William Lechner
Printed name of Principal Investigator

ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘
WĂŐĞϭŽĨϳ
,QIRUPHG&RQVHQWWR3DUWLFLSDWHLQD5HVHDUFK6WXG\
6WXG\7LWOH([DPLQLQJDOFRKROFRQVXPSWLRQSHUFHSWLRQVDQGXVHUH[SHULHQFHRIDOFRKROPRGHUDWLRQ
VWUDWHJLHV
3ULQFLSDO,QYHVWLJDWRU:LOOLDP/HFKQHU3K'
<RXDUHEHLQJLQYLWHGWRSDUWLFLSDWHLQDUHVHDUFKVWXG\7KLVFRQVHQWIRUPZLOOSURYLGH\RXZLWKLQIRUPDWLRQRQ
WKHUHVHDUFKSURMHFWZKDW\RXZLOOQHHGWRGRDQGWKHDVVRFLDWHGULVNVDQGEHQHILWVRIWKHUHVHDUFK<RXU
SDUWLFLSDWLRQLVYROXQWDU\3OHDVHUHDGWKLVIRUPFDUHIXOO\,WLVLPSRUWDQWWKDW\RXDVNTXHVWLRQVDQGIXOO\
XQGHUVWDQGWKHUHVHDUFKLQRUGHUWRPDNHDQLQIRUPHGGHFLVLRQ<RXZLOOUHFHLYHDFRS\RIWKLVGRFXPHQWWRWDNH
ZLWK\RX
3XUSRVH
:HDUHLQWHUHVWHGLQWHVWLQJWKHXVDELOLW\RIDDOFRKROPRGHUDWLRQVWUDWHJLHVDLPHGDWKHOSLQJXVHUVGULQNZLWKLQ
OLPLWVWKDWWKH\VHWIRUWKHPVHOYHVEHIRUHGULQNLQJ
3URFHGXUHV
:HZLOODVN\RXWRFRPSOHWHDEDWWHU\RIPHDVXUHVLQFOXGLQJTXHVWLRQVDERXWGHPRJUDSKLFVPHDVXUHVUHODWHGWR
DOFRKROXVHSV\FKRORJLFDOSV\FKLDWULFPHDVXUHVVXFKDVTXHVWLRQVDERXWV\PSWRPVRIDQ[LHW\RUGHSUHVVLRQ
DQGQHXURSV\FKRORJLFDODQGEHKDYLRUDOHFRQRPLFWDVNVWKDWPHDVXUH\RXUFRJQLWLYHSHUIRUPDQFHDQGSUHIHUHQFH
IRUVKRUWDQGORQJWHUPUHZDUGV7KHQZHZLOODVN\RXWRXWLOL]HDOFRKROPRGHUDWLRQVWUDWHJLHVGXULQJWKHWZR
ZHHNREVHUYDWLRQSHULRG/DVWO\ZHZLOODVN\RXWRFRPSOHWHWKHVDPHEDWWHU\RIPHDVXUHVRQFHDJDLQDIWHUWKH
WZRZHHNREVHUYDWLRQSHULRG
,QRUGHUWRSDUWLFLSDWHLQWKLVWDVN\RXPXVWKDYHDVPDUWSKRQHDQGEHZLOOLQJWRGRZQORDGDPRELOH
DSSOLFDWLRQ$OOVWXG\SURFHGXUHVDUHFRPSOHWHO\FRQILGHQWLDO7KHVWXG\ZLOOFRQVLVWRIRQHODERUDWRU\YLVLW
ZKLFKZLOOWDNHKRXUVWRFRPSOHWHDQGRQHRQOLQHIROORZXSVHVVLRQZKLFKZLOOWDNHKRXUVWRFRPSOHWH
UHVXOWLQJLQKRXUVRISDUWLFLSDWLRQLQWRWDO3DUWLFLSDWLRQDOVRFRQVLVWVRIDWZRZHHNREVHUYDWLRQSHULRGGXULQJ
ZKLFK\RXPD\EHDVNHGWRXVHDPRELOHDSSOLFDWLRQDFFHVVLEOHYLDVPDUWSKRQH,I\RXDUHDVNHGWRXWLOL]HWKLV
DSSOLFDWLRQ\RXZLOODOVREHUHTXLUHGWRVLJQDQGDJUHHWRWKH(QG8VHU/LFHQVH$JUHHPHQWDVVRFLDWHGZLWKWKH
DSSOLFDWLRQZKLFKLQFOXGHVDJUHHPHQWWRXVHWKHDSSOLFDWLRQDVDQHVWLPDWHRIWKHDOFRKROHIIHFWVDQGWRXVH
DOFRKROLI\RXFKRRVHLQDFFRUGDQFHZLWKDOOVWDWHDQGIHGHUDOODZV
%HQHILWV 
7KHUHDUHQRGLUHFWEHQHILWVWR\RXIRUSDUWLFLSDWLQJLQWKLVVWXG\<RXZLOOKDYHDFKDQFHWRFRQWULEXWHWRD
VFLHQWLILFVWXG\WKDWPD\KHOSSHRSOHLQWKHIXWXUH

ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘


WĂŐĞϮŽĨϳ
5LVNVDQG'LVFRPIRUWV
(PRWLRQDOGLVFRPIRUWPD\EHDVVRFLDWHGZLWKFRPSOHWLQJWKHDVVHVVPHQWVDQGTXHVWLRQQDLUHV7KH
TXHVWLRQQDLUHVXVHGLQWKLVVWXG\KDYHEHHQXVHGLQRWKHUVLPLODUUHVHDUFKVWXGLHV6RPHRIWKHTXHVWLRQVPD\EH
RIDQHPEDUUDVVLQJRUVHQVLWLYHQDWXUHDQGPD\PDNH\RXXQFRPIRUWDEOH7KHUHIRUH\RXDUHIUHHQRWWRDQVZHU
DQ\TXHVWLRQV\RXGRQRWZLVKWRDQVZHU7KHWLPHVSHQWFRPSOHWLQJWKLVVWXG\PD\UHSUHVHQWDQ
LQFRQYHQLHQFH$GGLWLRQDOO\WKHFXUUHQWVWXG\PD\UHTXLUHWKDW\RXGRZQORDGDQGXWLOL]HDPRELOHDSSOLFDWLRQ
WKLVDSSOLFDWLRQZLOOFROOHFWGDWDRQWKHWLPHDQGORFDWLRQ\RXDUHLQZKHQ\RXXVHWKHDSSOLFDWLRQ\RXULQWHUQHW
SURWRFRO,3QXPEHUDQGLQIRUPDWLRQ\RXHQWHULQWRWKHGDWDILHOGV8SRQFRPSOHWLRQXVHUVPD\FORVHWKHDSS
FRQFOXGLQJGDWDFROOHFWLRQ7KHUHLVQRJXDUDQWHHWKDWWKHXVHRIWKLVDSSZLOOSUHYHQWLQWR[LFDWLRQWKHSXUSRVH
RIWKLVDSSLVWRDVVLVWLQGLYLGXDOVVHHNLQJPRGHUDWLRQLQGULQNLQJKDELWV7KHXVHRIWKLVDSSPD\UHVXOWLQ
DOFRKROLQWR[LFDWLRQZKLFKPD\OHDGWRSRWHQWLDOKDUP
,03257$173/($6(5($'7+,6/,&(16(&$5()8//<$1',1,7,$/%()25(86,1*7+,6
62)7:$5(

/,&(16(

/HJDOO\%LQGLQJ$JUHHPHQW%\LQVWDOOLQJDQGRUXVLQJWKH6RFLDO'ULQNHUPRELOHGHYLFH
DSSOLFDWLRQKHUHLQDIWHUWKH6RIWZDUH\RXDJUHHWKLV(QG8VHU/LFHQVH$JUHHPHQWKHUHLQDIWHUWKH
³$JUHHPHQW´LVDOHJDOO\ELQGLQJDQGYDOLGFRQWUDFWDQGDJUHHWREHERXQGE\DOORIWKHWHUPVDQGFRQGLWLRQV
FRQWDLQHGKHUHLQ6SHFLILFDOO\EXWZLWKRXWDQ\OLPLWDWLRQ\RXDJUHHWRLQGHPQLI\UHOHDVHDQGKROG(YHQ
0RGHUDWLRQ//&DVWKHRZQHUZLWKDOOULJKWVDQGSULYLOHJHVWRWKH6RIWZDUHWKH³&RPSDQ\DQGDOORILWV
RIILFHUVPDQDJHUVHPSOR\HHVDJHQWVRUGLVWULEXWRUVIURPDQ\DQGDOOOLDELOLW\DVPRUHIXOO\GHVFULEHGDQG
DJUHHGWRKHUHLQ

8VHDQG5LJKWV/LPLWHGE\$JUHHPHQW6XEMHFWWRWKHWHUPVRIWKLV$JUHHPHQWWKH&RPSDQ\
JUDQWV\RXDOLPLWHGQRQH[FOXVLYHQRQWUDQVIHUDEOHOLFHQVHZLWKRXWULJKWWRVXEOLFHQVHWRXVHWKH6RIWZDUHLQ
DFFRUGDQFHZLWKWKLV$JUHHPHQW7KH&RPSDQ\GRHVQRWWUDQVIHUWKHWLWOHRI³6RFLDO'ULQNHU´WR\RXDQGWKH
OLFHQVHJUDQWHGWR\RXLVQRWDVDOH7KLV$JUHHPHQWLVDELQGLQJOHJDODJUHHPHQWEHWZHHQWKH&RPSDQ\DQGWKH
SXUFKDVHUVDQGXVHUVRIWKH6RIWZDUH,I\RXGRQRWDJUHHWREHERXQGE\WKLV$JUHHPHQW\RXDJUHHWRDQGVKDOO
LPPHGLDWHO\FHDVHXVHRIWKH6RIWZDUHDQGLPPHGLDWHO\UHPRYHWKH6RIWZDUHIURPDQ\DQGDOOHOHFWURQLFDQGRU
PRELOHGHYLFHVRZQHGRUFRQWUROOHGE\\RX
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV
'DWH

',675,%87,21

1R5LJKWWR'LVWULEXWH7KH6RIWZDUHDQGOLFHQVHJUDQWHGKHUHLQVKDOOQRWEHFRSLHGVKDUHG
GLVWULEXWHGUHVROGRIIHUHGIRUUHVDOHWUDQVIHUUHGRUVXEOLFHQVHGLQZKROHRULQSDUW

ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘
WĂŐĞϯŽĨϳ
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV
'DWH

86(5$*5((0(17

8VHRI6RIWZDUH8VHRIWKH6RIWZDUHLVOLPLWHGWRWKHQXPEHURIOLFHQVHVSXUFKDVHGE\\RX$
VLQJOHSXUFKDVHRIWKLV6RIWZDUHVKDOOJUDQW\RXRQHOLFHQVHWREHXVHGRQDVLQJOHHOHFWURQLFDQGRUPRELOH
GHYLFH

5HVWULFWLRQV<RXVKDOOXVH6RFLDO'ULQNHULQFRPSOLDQFHZLWKDQ\VWDWHORFDORUIHGHUDOODZRU
UHJXODWLRQRIWKH8QLWHG6WDWHVRUDQ\ODZRUUHJXODWLRQRIDQ\DSSOLFDEOHIRUHLJQMXULVGLFWLRQ

&RS\ULJKW5HVWULFWLRQ7KLV6RIWZDUHFRQWDLQVFRS\ULJKWHGPDWHULDOWUDGHVHFUHWVDQGRWKHU
SURSULHWDU\PDWHULDO<RXVKDOOQRWDQGVKDOOQRWDWWHPSWWRPRGLI\UHYHUVHHQJLQHHUGLVDVVHPEOHRU
GHFRPSLOHWKH6RIWZDUH<RXVKDOOQRWFUHDWHDQ\GHULYDWLYHZRUNVRURWKHUZRUNVWKDWDUHEDVHGXSRQRU
GHULYHGIURPWKH6RIWZDUHLQZKROHRULQSDUW
D
<RXDJUHHWKDW\RXVKDOOQRWXVHWKH&RPSDQ\
VQDPHORJRRUDQ\JUDSKLFVDVVRFLDWHG
WKHUHZLWKWKDWUHSUHVHQWWKH6RIWZDUHLQDQ\ZD\RUPDQQHUZKDWVRHYHU7KH&RPSDQ\UHWDLQVVROHDQG
H[FOXVLYHRZQHUVKLSRIDOOULJKWVWLWOHDQGLQWHUHVWLQDQGWRWKH6RIWZDUHDQGDOOLQWHOOHFWXDOSURSHUW\ULJKWV
UHODWLQJWKHUHWR
E
&RS\ULJKWODZDQGLQWHUQDWLRQDOFRS\ULJKWWUHDW\SURYLVLRQVSURWHFWDOOSDUWVRIWKH
6RIWZDUH1RSURJUDPFRGHSDUWLPDJHDXGLRVDPSOHRUWH[WPD\EHFRSLHGRUXVHGLQDQ\ZD\E\WKHXVHU
H[FHSWDVLQWHQGHGZLWKLQWKHERXQGVRIWKHRUGLQDU\DQGQHFHVVDU\XVHRIWKH6RIWZDUH$OOULJKWVQRWH[SUHVVO\
JUDQWHGKHUHXQGHUDUHUHVHUYHGIRUWKH&RPSDQ\
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV
'DWH

5(63216,%/(86(

(VWLPDWHV2QO\7KH6RIWZDUHSURYLGHVDQHVWLPDWHRIDXVHU¶VEORRGDOFRKROFRQWHQW³%$&´
RQO\DQG\RXDJUHHWKDW\RXVKDOOQRWUHO\LQDQ\ZD\XSRQWKHHVWLPDWHRI%$&SURYLGHGE\WKH6RIWZDUH
<RXDJUHHWKDW\RXVKDOOQRWUHO\XSRQWKH6RIWZDUHLQDQ\ZD\WRFRPSO\ZLWKDQ\DOFRKROFRQVXPSWLRQ
DOFRKROLPSDLUPHQWGULYLQJVWDWXWHRUDQ\RWKHUDSSOLFDEOHODZRUUHJXODWLRQRIDQ\MXULVGLFWLRQZKDWVRHYHU
LQFOXGLQJWKDWRIDQ\VWDWHORFDORUIHGHUDOODZRUUHJXODWLRQRIWKH8QLWHG6WDWHVRUDQ\DSSOLFDEOHODZRU
UHJXODWLRQRIDIRUHLJQMXULVGLFWLRQ

1R5HOLDQFH8SRQ(VWLPDWHG&DOFXODWLRQV7KHLQIRUPDWLRQGLVSOD\HGSURYLGHGDQGRU
JHQHUDWHGE\LQFOXGLQJDQ\XVHULQWHUDFWLRQZLWKWKH6RIWZDUHLQFOXGLQJDQ\WH[WJUDSKLFVLPDJHVDQGRWKHU
PDWHULDOSURYLGHGDUHHVWLPDWHVDQGDUHQRWWREHRWKHUZLVHUHOLHGXSRQE\WKHXVHU³&RQWHQW´7KH&RQWHQWLV


ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘


WĂŐĞϰŽĨϳ

QRWLQWHQGHGWREHDVXEVWLWXWHIRUSURIHVVLRQDOPHGLFDODGYLFHGLDJQRVLVRUWUHDWPHQW<RXVSHFLILFDOO\
DFNQRZOHGJHDQGDJUHHWRWKHIROORZLQJVWDQGDUGDOFRKROLFGULQNVRIHYHU\YDULHW\YDU\LQVL]HDQGDOFRKRO
FRQWHQWLQGLYLGXDODOFRKRODEVRUSWLRQDQGHOLPLQDWLRQUDWHVIOXFWXDWHDQG\RXUDFWXDO%$&ZLOOGLIIHUIURPWKH
UHVXOWRIDQ\FDOFXODWHGHVWLPDWHRI%$&VHWIRUWKE\WKH6RIWZDUH

1R0HGLFDO$GYLFH7KH6RIWZDUHGRHVQRWSURYLGHPHGLFDODGYLFH$OZD\VVHHNWKHDGYLFHRI
\RXUSK\VLFLDQRURWKHUTXDOLILHGKHDOWKSURYLGHUZLWKDQ\TXHVWLRQV\RXPD\KDYHUHJDUGLQJDPHGLFDODLOPHQW
FRQGLWLRQRUVXEVWDQFHGHSHQGHQF\LVVXH1HYHUGLVUHJDUGSURIHVVLRQDOPHGLFDODGYLFHRUGHOD\LQVHHNLQJD
SURIHVVLRQDORSLQLRQEHFDXVHRI\RXUXVHRIWKH6RIWZDUH

5HVSRQVLEOH8VH<RXDJUHHWKH6RIWZDUHVKDOORQO\EHXVHGLQDUHVSRQVLEOHPDQQHUDQGQRWDV
SDUWRIDQ\FRPSHWLWLRQRUFRQWHVWZKDWVRHYHU

BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB

BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV 



'DWH


',6&/$,0(52):$55$17<

12:$55$17,(6727+()8//(67(;7(173266,%/(%</$:7+(&203$1<
'2(6127:$55$177+$77+(62)7:$5(:,//23(5$7((5525)5((257+$77+(
62)7:$5(,6)5((2)25,1$1<:$<686&(37,%/(72$&20387(59,5862527+(5
+$50)8/0(&+$1,606,)<28586(2)7+(62)7:$5(5(68/76,17+(1((')25
6(59,&,1*255(3/$&,1*(48,30(1725'$7$25$1<27+(5&26767+(&203$1<,6
1275(63216,%/()257+26(&26767+(62)7:$5(,63529,'('³$6,6´:,7+287$1<
:$55$17,(62)$1<.,1'7+(&203$1<727+()8//(67(;7(173(50,77('%</$:
',6&/$,06$//:$55$17,(6:+(7+(5(;35(6625,03/,(',1&/8',1*7+(:$55$17<
2)0(5&+$17$%,/,7<),71(66)253$57,&8/$5385326($1'121,1)5,1*(0(177+(
&203$1<0$.(612:$55$17,(6$%2877+($&&85$&<5(/,$%,/,7<$1'
&203/(7(1(66257,0(/,1(662)7+(&217(173529,'('%<7+(62)7:$5(

BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB

BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV 



'DWH









ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘


WĂŐĞϱŽĨϳ




&216(172)86(2)'$7$

&RQVHQWRI'DWD&ROOHFWLRQ<RXDJUHHWKH&RPSDQ\PD\FROOHFWDQGXVHLQIRUPDWLRQJDWKHUHG
LQDQ\PDQQHUE\WKH6RIWZDUHDQGKDVWKHIXOOULJKWSHUPLVVLRQDQGDXWKRUL]DWLRQWRXWLOL]HVXFKLQIRUPDWLRQ
IRUDQ\UHVHDUFKVFLHQWLILFRUFRPPHUFLDOSXUSRVHZKDWVRHYHULQFOXGLQJWKHUHOHDVHXWLOL]DWLRQDQGRUVDOHRI
VXFKLQIRUPDWLRQWRDWKLUGSDUW\RUDVSDUWRIDQ\SURGXFWVXSSRUWVHUYLFHVSURYLGHGWR\RX7KH&RPSDQ\PD\
XVHDQ\LQIRUPDWLRQFRPSLOHGE\WKH6RIWZDUHWRSHULRGLFDOO\SURYLGHQRWLFHRULQIRUPDWLRQWR\RXLQFOXGLQJ
EXWQRWOLPLWHGWRDQ\WKLUGSDUW\DGYHUWLVHPHQWV

BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB

BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV 



'DWH


0,6&(//$1(286

,QGHPQLILFDWLRQ<RXZLOOLQGHPQLI\UHOHDVHKROGKDUPOHVVDQGSD\DOOFRVWVDVVRFLDWHGZLWK
DOHJDOGHIHQVHRIWKH&RPSDQ\LWVRIILFHUVPDQDJHUVHPSOR\HHVDJHQWVDQGGLVWULEXWRUVDJDLQVWDQ\DQGDOO
FODLPVSURFHHGLQJVGHPDQGVRUFRVWVLQFOXGLQJEXWQRWOLPLWHGWRWKDWDULVLQJIURPDQ\DQGDOOLQMXU\
OLDELOLW\RUFODLPRILQMXU\WRRUGHDWKRIDQ\SHUVRQRUIRUORVVRIRUGDPDJHWRSURSHUW\UHVXOWLQJIURPRULQ
DQ\ZD\FRQQHFWHGGLUHFWO\RULQGLUHFWO\ZLWKXVHRIWKH6RIWZDUH

5HOHDVHRI'DPDJHV,QQRHYHQWLQFOXGLQJZLWKRXWOLPLWDWLRQLQWKHHYHQWRIQHJOLJHQFHZLOO
WKH&RPSDQ\LWVRIILFHUVPDQDJHUVHPSOR\HHVDJHQWVRUGLVWULEXWRUVEHOLDEOHIRUDQ\FRQVHTXHQWLDO
LQFLGHQWDOLQGLUHFWVSHFLDORUSXQLWLYHGDPDJHVZKDWVRHYHULQFOXGLQJZLWKRXWOLPLWDWLRQGDPDJHVIRUORVVRI
SURILWVORVVRIXVHEXVLQHVVLQWHUUXSWLRQORVVRILQIRUPDWLRQRUGDWDRUSHFXQLDU\ORVVLQFRQQHFWLRQZLWKRU
DULVLQJRXWRIRUUHODWHGWRWKLV$JUHHPHQWWKH6RIWZDUHRUWKHXVHRULQDELOLW\WRXVHWKH6RIWZDUHRUWKH
IXUQLVKLQJSHUIRUPDQFHRUXVHRIDQ\RWKHUPDWWHUVKHUHXQGHUZKHWKHUEDVHGXSRQFRQWUDFWWRUWRUDQ\RWKHU
WKHRU\LQFOXGLQJQHJOLJHQFH

*RYHUQLQJ/DZ7KLV$JUHHPHQWVKDOOEHJRYHUQHGE\DQGLQWHUSUHWHGDQGHQIRUFHGLQ
DFFRUGDQFHZLWKWKHVXEVWDQWLYHODZVRIWKH6WDWHRI3HQQV\OYDQLDLQFOXGLQJZLWKRXWOLPLWDWLRQSURYLVLRQV
FRQFHUQLQJOLPLWDWLRQVRIDFWLRQVZLWKRXWUHIHUHQFHWRWKHFRQIOLFWVRIODZVUXOHVRIWKDWRUDQ\RWKHU
MXULVGLFWLRQH[FHSWWKDW)HGHUDOODZVVKDOODOVRDSSO\WRWKHH[WHQWUHOHYDQW

&RQVHQWWR-XULVGLFWLRQ<RXKHUHE\LLUUHYRFDEO\VXEPLWWRWKHMXULVGLFWLRQRIWKH&RXUWRI
&RPPRQ3OHDVLQ(ULH&RXQW\RUWKH86'LVWULFW&RXUWIRUWKH:HVWHUQ'LVWULFWLQDQ\DFWLRQDULVLQJRXWRIWKLV
$JUHHPHQWLLDJUHHWKDWDOOFODLPVLQVXFKDFWLRQPD\EHGHFLGHGLQVXFKFRXUWLLLZDLYHVWRWKHIXOOHVW
H[WHQWLWPD\HIIHFWLYHO\GRVRWKHGHIHQVHRIDQLQFRQYHQLHQWIRUXPDQGLYFRQVHQWVWRWKHVHUYLFHRISURFHVV
E\PDLO$ILQDOMXGJPHQWLQDQ\VXFKDFWLRQVKDOOEHFRQFOXVLYHDQGPD\EHHQIRUFHGLQRWKHUMXULVGLFWLRQV

6HYHUDELOLW\,IDQ\SURYLVLRQRIWKLV$JUHHPHQWRUWKHDSSOLFDWLRQWKHUHRIWRDQ\SHUVRQRU
FLUFXPVWDQFHLVKHOGLQYDOLGRUXQHQIRUFHDEOHWRDQ\H[WHQWWKHUHPDLQGHURIWKLV$JUHHPHQWDQGWKHDSSOLFDWLRQ


ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘


WĂŐĞϲŽĨϳ

RIWKDWSURYLVLRQWRDQ\RWKHUSHUVRQVRUFLUFXPVWDQFHVKDOOQRWEHDIIHFWHGWKHUHE\DQGWKDWSURYLVLRQVKDOOEH
HQIRUFHGWRWKHJUHDWHVWH[WHQWSHUPLWWHGE\ODZ

7HUPLQDWLRQ$Q\IDLOXUHWRFRPSO\ZLWKWKHWHUPVDQGFRQGLWLRQVRIWKLV$JUHHPHQWZLOOUHVXOW
LQDXWRPDWLFDQGLPPHGLDWHWHUPLQDWLRQRIWKLVOLFHQVH8SRQWHUPLQDWLRQRIWKLVOLFHQVHJUDQWHGKHUHLQIRUDQ\
UHDVRQ\RXDJUHHWRLPPHGLDWHO\FHDVHXVHRIWKH6RIWZDUHDQGGHVWUR\DOOFRSLHVRIWKH6RIWZDUHVXSSOLHG
XQGHUWKLV$JUHHPHQW

BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB

BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW,QLWLDOV 



'DWH


$OWHUQDWLYHV
<RXPD\FKHFNWKHOLVWRI621$VWXGLHVDQGILQGDQDOWHUQDWLYHVWXG\WKDW\RXFDQFRPSOHWHWKDWSURYLGHVWKH
FRXUVHFUHGLWUHTXLUHGIRU\RX

3ULYDF\DQG&RQILGHQWLDOLW\
,GHQWLI\LQJLQIRUPDWLRQZLOOQRWEHLQFOXGHGLQWKHGDWDWKDW\RXSURYLGH<RXUVWXG\UHODWHGLQIRUPDWLRQZLOOEH
NHSWFRQILGHQWLDOZLWKLQWKHOLPLWVRIWKHODZ$Q\LGHQWLI\LQJLQIRUPDWLRQZLOOEHNHSWLQDVHFXUHORFDWLRQDQG
RQO\WKHUHVHDUFKHUVZLOOKDYHDFFHVVWRWKHGDWD5HVHDUFKSDUWLFLSDQWVZLOOQRWEHLGHQWLILHGLQDQ\SXEOLFDWLRQ
RUSUHVHQWDWLRQRIUHVHDUFKUHVXOWVRQO\DJJUHJDWHGDWDZLOOEHXVHG<RXUUHVHDUFKLQIRUPDWLRQPD\LQFHUWDLQ
FLUFXPVWDQFHVEHGLVFORVHGWRWKH,QVWLWXWLRQDO5HYLHZ%RDUG,5%ZKLFKRYHUVHHVUHVHDUFKDW.HQW6WDWH
8QLYHUVLW\RUWRFHUWDLQIHGHUDODJHQFLHV&RQILGHQWLDOLW\PD\QRWEHPDLQWDLQHGLI\RXLQGLFDWHWKDW\RXPD\GR
KDUPWR\RXUVHOIRURWKHUV

&RPSHQVDWLRQ
<RXZLOOEHFRPSHQVDWHGIRUWKHEDVHOLQHODERUDWRU\VHVVLRQDQGIRUWKHRQOLQHIROORZXSVHVVLRQIRUD
WRWDORIIRUFRPSOHWLQJWKHVWXG\

9ROXQWDU\3DUWLFLSDWLRQ
7DNLQJSDUWLQWKLVUHVHDUFKVWXG\LVHQWLUHO\XSWR\RX<RXPD\FKRRVHQRWWRSDUWLFLSDWHRU\RXPD\
GLVFRQWLQXH\RXUSDUWLFLSDWLRQDWDQ\WLPHZLWKRXWSHQDOW\RUORVVRIEHQHILWVWRZKLFK\RXDUHRWKHUZLVH
HQWLWOHG<RXZLOOEHLQIRUPHGRIDQ\QHZUHOHYDQWLQIRUPDWLRQWKDWPD\DIIHFW\RXUKHDOWKZHOIDUHRU
ZLOOLQJQHVVWRFRQWLQXH\RXUVWXG\SDUWLFLSDWLRQ

&RQWDFW,QIRUPDWLRQ
,I\RXKDYHDQ\TXHVWLRQVRUFRQFHUQVDERXWWKLVUHVHDUFK\RXPD\FRQWDFW:LOOLDP/HFKQHUDW
ZOHFKQHU#NHQWHGXRU7KLVSURMHFWKDVEHHQDSSURYHGE\WKH.HQW6WDWH8QLYHUVLW\

ǆĂŵŝŶŝŶŐĂůĐŽŚŽůĐŽŶƐƵŵƉƚŝŽŶ͕ƉĞƌĐĞƉƚŝŽŶƐ͕ĂŶĚƵƐĞƌĞǆƉĞƌŝĞŶĐĞŽĨĂůĐŽŚŽůŵŽĚĞƌĂƚŝŽŶƐƚƌĂƚĞŐŝĞƐ͘
WĂŐĞϳŽĨϳ
,QVWLWXWLRQDO5HYLHZ%RDUG,I\RXKDYHDQ\TXHVWLRQVDERXW\RXUULJKWVDVDUHVHDUFKSDUWLFLSDQWRUFRPSODLQWV
DERXWWKHUHVHDUFK\RXPD\FDOOWKH,5%DW
&RQVHQW6WDWHPHQWDQG6LJQDWXUH
,KDYHUHDGWKLVFRQVHQWIRUPDQGKDYHKDGWKHRSSRUWXQLW\WRKDYHP\TXHVWLRQVDQVZHUHGWRP\VDWLVIDFWLRQ,
YROXQWDULO\DJUHHWRSDUWLFLSDWHLQWKLVVWXG\,XQGHUVWDQGWKDWDFRS\RIWKLVFRQVHQWZLOOEHSURYLGHGWRPHIRU
IXWXUHUHIHUHQFH
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBB
3DUWLFLSDQW6LJQDWXUH
'DWH

9(5%$/&216(1772$&7$6$5(6($5&+68%-(&7
([DPLQLQJ$OFRKRO&RQVXPSWLRQ3HUFHSWLRQVDQG
8VHU([SHULHQFHRI$OFRKRO0RGHUDWLRQ6WUDWHJLHV
'U:LOOLDP/HFKQHUDQGKLVDVVRFLDWHVDUHLQWHUHVWHGLQWHVWLQJWKHXVDELOLW\RIDOFRKROPRGHUDWLRQ
VWUDWHJLHVDLPHGDQGKHOSLQJXVHUVGULQNZLWKLQOLPLWVWKDWWKH\VHWIRUWKHPVHOYHVEHIRUHGULQNLQJ
7KHSXUSRVHRIWKLVVFUHHQLQJLVWRGHWHUPLQH\RXUHOLJLELOLW\IRUWKHUHVHDUFKVWXG\DQGZLOOWDNH
DSSUR[LPDWHO\PLQXWHV,I\RXDJUHHWRSDUWLFLSDWHLQWKLVVFUHHQLQJ\RXZLOOEHDVNHGVRPHTXHVWLRQV
UHJDUGLQJ\RXUVXEVWDQFHXVH,I\RXDUHHOLJLEOHZHZLOOVFKHGXOHWKHPDLQVWXG\VHVVLRQLQFOXGLQJWKH
LQIRUPHGFRQVHQWSURFHVVDFOLQLFDOLQWHUYLHZTXHVWLRQQDLUHVDQGFRPSXWHUWDVNVDW.68ZKLFKZLOO
WDNHDERXWKRXUV7KHQZHZLOODVN\RXWRXWLOL]HDQGPRQLWRU\RXUXVHRIDOFRKROPRGHUDWLRQ
VWUDWHJLHVIRUWZRZHHNV/DVWO\ZHZLOODVN\RXWRFRPSOHWHDQRQOLQHIROORZXSVXUYH\DIWHUWKHWZR
ZHHNSHULRG7KHHQWLUHVWXG\ZLOOWDNHXSWRKRXUVWRFRPSOHWHDQG\RXFDQHDUQIRU\RXU
SDUWLFLSDWLRQ
3DUWLFLSDWLRQLQWKLVSKRQHVFUHHQPD\LQYROYHVRPHDGGHGULVNVRUGLVFRPIRUWV%HLQJDVNHGTXHVWLRQV
UHODWHGWRVXEVWDQFHXVHPD\FDXVHDQ[LHW\RUHPEDUUDVVPHQWGXHWRWKHSHUVRQDOQDWXUHRIWKHTXHVWLRQV
<RXPD\GHFOLQHWRDQVZHUDQ\LWHP,I\RXH[SHULHQFHDQ\DQ[LHW\RUHPEDUUDVVPHQW\RXKDYHWKH
RSWLRQWRGLVFXVVWKLVZLWK'U:LOOLDP/HFKQHUWKHSULPDU\LQYHVWLJDWRURIWKLVVWXG\
<RXUUHVSRQVHVWRWKLVSKRQHVFUHHQZLOOEHUHFRUGHGRQDIRUPLGHQWLILHGE\DQ,'QXPEHUDQGGRHVQRW
LQFOXGH\RXUQDPHRURWKHULGHQWLI\LQJLQIRUPDWLRQ,I\RXDUHLQHOLJLEOHIRUWKHVWXG\WKHIRUPRQ
ZKLFK,UHFRUG\RXUUHVSRQVHVZLOOEHGHVWUR\HGLPPHGLDWHO\,I\RXDUHHOLJLEOHDQGGHFLGHWRWDNHSDUW
LQWKHVWXG\\RXUUHFRUGHGUHVSRQVHVZLOOEHVHFXUHO\VWRUHGVHSDUDWHGIURPDQ\LGHQWLI\LQJ
LQIRUPDWLRQ
'R\RXKDYHDQ\TXHVWLRQVDERXWWKLVSKRQHVFUHHQ",I\RXKDYHRWKHUTXHVWLRQV\RXPD\UHDFK'U
/HFKQHUDWIRUPRUHLQIRUPDWLRQDERXWWKLVVWXG\
3DUWLFLSDWLRQLQWKLVWHOHSKRQHVFUHHQLVHQWLUHO\YROXQWDU\<RXPD\UHIXVHWRSDUWLFLSDWHRUZLWKGUDZDW
DQ\WLPHZLWKRXWSHQDOW\RUORVVRIEHQHILWVWRZKLFK\RXDUHHQWLWOHG
5HVHDUFKUHFRUGVZLOOEHNHSWFRQILGHQWLDO'R\RXDJUHHWRSDUWLFLSDWH"<(612
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
3ULQWHG1DPHRI3DUWLFLSDQW
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBB
6LJQDWXUHRI3HUVRQ2EWDLQLQJ9HUEDO&RQVHQW
'DWH

ZĞƐĞĂƌĐŚƉĂƌƚŝĐŝƉĂŶƚƐǁĂŶƚĞĚĨŽƌĂƐƚƵĚǇ
ĂƐƐĞƐƐŝŶŐƐƚƌĂƚĞŐŝĞƐƚŽĐŽŶƚƌŽůĚƌŝŶŬŝŶŐ͘
WĂƌƚŝĐŝƉĂŶƚƐŵƵƐƚ͗

ĞϮϭǇĞĂƌƐŽƌŽůĚĞƌ

ƌŝŶŬĂůĐŽŚŽůƌĞŐƵůĂƌůǇ

KǁŶĂƐŵĂƌƚƉŚŽŶĞ
/ŶƚŚŝƐƐƚƵĚǇǁĞǁŝůůĂƐŬǇŽƵƚŽĐŽŵƉůĞƚĞĂƚǁŽŚŽƵƌƐĞƐƐŝŽŶĂƚ<ĞŶƚ
^ƚĂƚĞhŶŝǀĞƌƐŝƚǇƚŚĂƚŝŶĐůƵĚĞƐƋƵĞƐƚŝŽŶƐƌĞůĂƚĞĚƚŽĂůĐŽŚŽůƵƐĞ͕
ƐǇŵƉƚŽŵƐŽĨĂŶǆŝĞƚǇŽƌĚĞƉƌĞƐƐŝŽŶ͕ĂŶĚŶĞƵƌŽƉƐǇĐŚŽůŽŐŝĐĂůƚĂƐŬƐƚŚĂƚ
ŵĞĂƐƵƌĞǇŽƵƌĐŽŐŶŝƚŝǀĞƉĞƌĨŽƌŵĂŶĐĞ͘ƚƚŚĞĞŶĚŽĨƚŚŝƐƐĞƐƐŝŽŶǁĞǁŝůů
ĞǆƉůĂŝŶƚĞĐŚŶŝƋƵĞƐĨŽƌĐŽŶƚƌŽůůŝŶŐŽƌůŝŵŝƚŝŶŐǇŽƵƌĚƌŝŶŬŝŶŐʹŝĨǇŽƵ
ĐŚŽŽƐĞƚŽĚŽƐŽ͘dŚĞŶǁĞǁŝůůĂƐŬǇŽƵƚŽŵŽŶŝƚŽƌǇŽƵƌĚƌŝŶŬŝŶŐ;ŚŽǁ
ŵĂŶǇĚƌŝŶŬƐƉĞƌĚĂǇǇŽƵŚĂǀĞͿĨŽƌĂƚǁŽͲǁĞĞŬƉĞƌŝŽĚ͘&ŝŶĂůůǇ͕ǁĞǁŝůů
ƐĞŶĚǇŽƵĂůŝŶŬƚŽĐŽŵƉůĞƚĞŽƵƚĐŽŵĞŵĞĂƐƵƌĞƐĂƐŬŝŶŐƚŚĞƐĂŵĞ
ƋƵĞƐƚŝŽŶƐǇŽƵĐŽŵƉůĞƚĞĚŝŶƚŚĞůĂďŽƌĂƚŽƌǇƐĞƐƐŝŽŶʹƚŚŝƐǁŝůůƚĂŬĞĂďŽƵƚ
ƚǁŽŚŽƵƌƐƚŽĐŽŵƉůĞƚĞ͘ůůƐĞƐƐŝŽŶƐĂƌĞĐŽŵƉůĞƚĞůǇĐŽŶĨŝĚĞŶƚŝĂů͘
ŽŵƉĞŶƐĂƚŝŽŶ͗WĂƌƚŝĐŝƉĂŶƚƐǁŝůůďĞĐŽŵƉĞŶƐĂƚĞĚΨϰϬĨŽƌĐŽŵƉůĞƚŝŶŐ
ƚŚĞĨŝƌƐƚϮͲŚŽƵƌƐĞƐƐŝŽŶĂƚ<ĞŶƚ^ƚĂƚĞĂŶĚĂŶĂĚĚŝƚŝŽŶĂůΨϰϬĨŽƌ
ĐŽŵƉůĞƚŝŶŐƚŚĞĨŝŶĂůĂƐƐĞƐƐŵĞŶƚŽŶůŝŶĞͲΨϴϬŝŶƚŽƚĂů͘
/ĨǇŽƵĂƌĞŝŶƚĞƌĞƐƚĞĚ͕ƉůĞĂƐĞĐŽŶƚĂĐƚƐƚƵĚǇƉĞƌƐŽŶŶĞůǀŝĂĞŵĂŝůŽƌ
ƉŚŽŶĞ͗
>ĞĐŚŶĞƌůĂďΛŐŵĂŝů͘ĐŽŵ
;ϯϯϬͿϲϳϮͲϯϳϴϲ͘


Page 5 of 22
IRB LOG NUMBER: 16-
Page 5 of 22
Form Date: August 2016  Revision 6.0
In general, mobile technologies have been shown to be useful in providing treatment information for a wide-
range of health related behaviors for which individuals often fail to seek professional help (Cohn, Hunter-
Reel, Hagman, & Mitchell, 2011). Systematic reviews suggest that mobile digital interventions can reduce 
alcohol use in adults (Fowler, Holt, & Joshi, 2016). Preliminary evidence suggests that non treatment-seeking 
young adults will engage with a mobile text message intervention incorporating self-regulation support 
features, and that depending on level of engagement users may meet their drinking goals – suggesting 
promise for mobile based alcohol reduction interventions (Suffoletto, Chung, Muench, Monti, & Clark, 
2018). However, questions regarding the mechanisms, reliability, and magnitude of these effects remain 
unanswered.

Page 6 of 22
IRB LOG NUMBER: 16-
Page 6 of 22
Form Date: August 2016  Revision 6.0
3e.
Identify and describe the interventions and interactions that are to be performed solely for the research 
study.  Procedures/interventions should listed sequentially and be separated into paragraphs in the space below.

Page 7 of 22
IRB LOG NUMBER: 16-
Page 7 of 22
Form Date: August 2016  Revision 6.0
Participants will be recruited using the Kent State University SONA system and from the community via 
flyers and online advertisement. Eligible participants will meet the following inclusion criteria 1) be age 21 or 
older, 2) report experiencing at least three negative consequence of alcohol use in the past month (assessed 
via Brief Young Adult Alcohol Consequences Questionnaire: BYAACQ), 3) report having consumed at least 
5 drinks (for men) or 4 drinks (for women) on one or more occasions in the past 2-weeks 4) not be seeking 
treatment for alcohol use from a health-care provider, and 5) have access to a smartphone and 6) endorse 
some importance in changing their drinking (2 or greater on Alcohol Ladder Scale importance to change). 
Participants who endorse seeking treatment for alcohol related problems from a health care provider will be 
provided with a list of university sponsored and community based treatment providers. 
     Participants (n=64) will complete a battery of assessments detailed below including (1) demographic 
measures, (2) alcohol and substance use measures, (3) psychological measures, (4) behavioral economic and 
(5) neuropsychological measures.  
(1) Demographic Measures: will include brief questions about demographic characteristics biological sex, 
race, and socio-economic status. 
(2) Alcohol and Other Substance Use: The Timeline Follow-back Interview will be used to assess alcohol 
use over the prior 30 days[1]. The Implicit Association Test is a reaction time task requiring participants to 
manipulate alcohol related stimuli and has been shown to be a reliable measure of automatic impulses to 
drink alcohol [2, 3]. The Young Adult Alcohol Consequences Questionnaire (YAACQ ) will be used to 
assess a range of negative consequences of alcohol use that young adults may experience (e.g., while drinking 
in the past month, I have said or done embarrassing things). Assessment of Diagnostic and Statistical Manual 
of Psychiatric Disorders V (DSM-V)[4] alcohol related symptoms (e.g.  During the times when you drank 
alcohol, did you end up drinking more than you planned when you started?). The Drinking Motive 
Questionnaire Revised Short Form (DMQ–R SF): assesses motives for drinking in adolescents and young 
adults in four categories (social, coping, enhancement, social pressure)[5]. The Alcohol Expectancies Brief[6] 
measures positive and negative expectancies of alcohol use. Alcohol Contemplation Ladder is a measure of 
importance and motivation to make a change in one’s alcohol consumption[7]. Smoking History/Dependence 
Questionnaire: Smoking history and life smoking patterns will be assessed as recommended by the National 
Cancer Institute consensus panel (e.g. have you ever used tobacco products; how often do you use tobacco 
products). The Self-Report Habit Index (SRHI) measures adult habitual substance use . Additional questions 
regarding substance use history (specifically pertaining to age of onset and frequency of use for various 
illicit/unregulated substances) will also be administered. 
(3-5) Neuropsychological, Behavioral Economic, and Psychological Measures: Working Memory 
Performance and Inhibition will be measured using the National Institute of Health Examiner (Executive 
Abilities) [8]. The Monetary Choice Questionnaire (Delay Discounting) is a behavioral economic measure for 
assessing state in subjective value of delayed rewards, with greater discounting of value indicative of 
decreased self-control[9, 10]. Psychological Measures: will include The UPPS-P Impulsive Behavior Scale: a 
self-report that assesses five subscales that are used to measure distinct dimensions of impulsive 
behavior[11]. The Difficulties in Emotional Regulation Scale (DERS) will be used to measure the ability to 
utilize several emotion regulation strategies. The Positive and Negative Affect Scale will be administered to 
measure changes in affect[12]. Symptoms of depression, anhedonia, and anxiety will be assessed using the 
Center for Epidemiologic Studies –Depression Scale (CES-D)[13], SHAPS Anhedonia scale[14], and 
Generalized Anxiety Disorder 7-item (GAD-7)[15].

Page 8 of 22
IRB LOG NUMBER: 16-
Page 8 of 22
Form Date: August 2016  Revision 6.0
Following this initial baseline assessment, participants will be randomized to one of two experimental 
conditions detailed below. If they are randomized to Alcohol Moderation Group 1 they will receive a link to 
access the Alcohol Moderation software via smartphone, and a brief demonstration on how to utilize the 
application will be provided by trained research assistants. Participants will be asked to use the application if 
they consume alcohol at any point during the two-week observation period. Participants will not be 
encouraged to use alcohol, and will be clearly informed that there will be no penalty for not using the 
application during a drinking session or not drinking at all during the two-week observation period.  
Alcohol Moderation Group 1: Alcohol Moderation group 1 will be introduced to alcohol moderation 
strategies developed by the National Institute on Alcohol Abuse and Alcoholism. In addition to introducing 
participants to these drinking moderation strategies they will be asked to download and utilize the Social 
Drinker application, which addresses many of the strategies. A full description is listed below. 
Small changes can make a big difference in reducing your chances of having alcohol-related problems. 
Whatever strategies you choose, give them a fair trial. If one approach doesn't work, try something else. But 
if you haven't made progress in cutting down after 2 to 3 months, consider quitting drinking altogether, 
seeking professional help, or both.
Here are some strategies to try, and you can add your own at the end. Identify perhaps two or three to try in 
the next week or two. 
Keep track. Keep track of how much you drink. Find a way that works for you: Carry a drinking tracker card 
in your wallet, make check marks on a kitchen calendar, or enter notes in a mobile phone notepad or 
personal digital assistant. Making note of each drink before you drink it may help you slow down when 
needed. 
Count and measure. Know the standard drink sizes so you can count your drinks accurately. Measure drinks 
at home. Away from home, it can be hard to keep track, especially with mixed drinks, and at times, you may 
be getting more alcohol than you think. With wine, you may need to ask the host or server not to "top off" a 
partially filled glass.
Set goals. Decide how many days a week you want to drink and how many drinks you'll have on those days. 
It's a good idea to have some days when you don't drink. People who always stay within the low-risk limits 
when they drink have the lowest rates of alcohol-related problems.
Pace and space. When you do drink, pace yourself. Sip slowly. Have no more than one standard drink with 
alcohol per hour. Have "drink spacers"—make every other drink a non-alcoholic one, such as water, soda, or 
juice.
Include food. Don't drink on an empty stomach. Eat some food so the alcohol will be absorbed into your 
system more slowly.
Find alternatives. If drinking has occupied a lot of your time, then fill free time by developing new, healthy 
activities, hobbies, and relationships, or renewing ones you've missed. If you have counted on alcohol to be 
more comfortable in social situations, manage moods, or cope with problems, then seek other, healthy ways 
to deal with those areas of your life.

Page 9 of 22
IRB LOG NUMBER: 16-
Page 9 of 22
Form Date: August 2016  Revision 6.0
Avoid "triggers." What triggers your urge to drink? If certain people or places make you drink even when 
you don't want to, try to avoid them. If certain activities, times of day, or feelings trigger the urge, plan 
something else to do instead of drinking. If drinking at home is a problem, keep little or no alcohol there.
Plan to handle urges. When you cannot avoid a trigger and an urge hits, consider these options: Remind 
yourself of your reasons for changing (it can help to carry them in writing or store them in an electronic 
message you can access easily). Or talk things through with someone you trust. Or get involved with a 
healthy, distracting activity, such as physical exercise or a hobby that doesn't involve drinking. Or, instead of 
fighting the feeling, accept it and ride it out without giving in, knowing that it will soon crest like a wave and 
pass. Also, see the short module to help you handle urges to drink.
Know your "no." You're likely to be offered a drink at times when you don't want one. Have a polite, 
convincing "no, thanks" ready. The faster you can say no to these offers, the less likely you are to give in. If 
you hesitate, it allows you time to think of excuses to go along. Also, see the short module to help you build 
drink refusal skills.
Many of these strategies are addressed within a mobile application we have developed. In this study we will 
ask you to utilize  an application called Social Drinker to keep track of your drinking. The Social Drinker ( 
http://socialdrinkerapp.com/ ) mobile application utilizes individually entered user information to monitor 
alcohol consumption and provide feedback for the pace of alcohol consumption in real time. The application 
works by reordering a standardized algebraic formula for calculating blood alcohol content. You will enter 
sex, weight, time since last meal, and alcohol consumption limits. You will be presented with a list of blood 
alcohol content (BAC) percentages accompanied with descriptions of the effects of these BAC levels on 
important cognitive functions including memory, coordination, and social adeptness. The program then uses 
these values to design a blood alcohol content curve which is used to pace your alcohol consumption over the 
period of time that you are consuming alcohol. Once the BAC curve is established you just wait to start your 
next drink until the program notifies you (a buzz in your pocket). 
Alcohol Moderation Group 2:   
Alcohol moderation Group 2 will be exposed to the National Institute of Alcohol Abuse and Alcoholism 
strategies for moderation, without access to the Social Drinker Application. 
Small changes can make a big difference in reducing your chances of having alcohol-related problems. 
Whatever strategies you choose, give them a fair trial. If one approach doesn't work, try something else. But 
if you haven't made progress in cutting down after 2 to 3 months, consider quitting drinking altogether, 
seeking professional help, or both.
Here are some strategies to try, and you can add your own at the end. Identify perhaps two or three to try in 
the next week or two. 
Keep track. Keep track of how much you drink. Find a way that works for you: Carry a drinking tracker card 
in your wallet, make check marks on a kitchen calendar, or enter notes in a mobile phone notepad or 
personal digital assistant. Making note of each drink before you drink it may help you slow down when 
needed. 
Count and measure. Know the standard drink sizes so you can count your drinks accurately. Measure drinks 
at home. Away from home, it can be hard to keep track, especially with mixed drinks, and at times, you may 

Page 10 of 22
IRB LOG NUMBER: 16-
Page 10 of 22
Form Date: August 2016  Revision 6.0
be getting more alcohol than you think. With wine, you may need to ask the host or server not to "top off" a 
partially filled glass.
Set goals. Decide how many days a week you want to drink and how many drinks you'll have on those days. 
It's a good idea to have some days when you don't drink. People who always stay within the low-risk limits 
when they drink have the lowest rates of alcohol-related problems.
Pace and space. When you do drink, pace yourself. Sip slowly. Have no more than one standard drink with 
alcohol per hour. Have "drink spacers"—make every other drink a non-alcoholic one, such as water, soda, or 
juice.
Include food. Don't drink on an empty stomach. Eat some food so the alcohol will be absorbed into your 
system more slowly.
Find alternatives. If drinking has occupied a lot of your time, then fill free time by developing new, healthy 
activities, hobbies, and relationships, or renewing ones you've missed. If you have counted on alcohol to be 
more comfortable in social situations, manage moods, or cope with problems, then seek other, healthy ways 
to deal with those areas of your life.
Avoid "triggers." What triggers your urge to drink? If certain people or places make you drink even when 
you don't want to, try to avoid them. If certain activities, times of day, or feelings trigger the urge, plan 
something else to do instead of drinking. If drinking at home is a problem, keep little or no alcohol there.
Plan to handle urges. When you cannot avoid a trigger and an urge hits, consider these options: Remind 
yourself of your reasons for changing (it can help to carry them in writing or store them in an electronic 
message you can access easily). Or talk things through with someone you trust. Or get involved with a 
healthy, distracting activity, such as physical exercise or a hobby that doesn't involve drinking. Or, instead of 
fighting the feeling, accept it and ride it out without giving in, knowing that it will soon crest like a wave and 
pass. Also, see the short module to help you handle urges to drink.
Know your "no." You're likely to be offered a drink at times when you don't want one. Have a polite, 
convincing "no, thanks" ready. The faster you can say no to these offers, the less likely you are to give in. If 
you hesitate, it allows you time to think of excuses to go along. Also, see the short module to help you build 
drink refusal skills.
Following the two week observation period participants will repeat baseline assessment procedures 
including: (2) alcohol and substance use measures, (3) psychological measures, (4) Behavioral Economic 
and (5) neuropsychological measures. Additionally, participants will complete questionnaires assessing their 
experience while using 1) the moderation strategies detailed above and 2) [for participants using the mobile 
application] specific questions regarding use of the application (e.g. The mobile application was easy to use; 
I would use this mobile application to help monitor my alcohol use). The follow-up measures will be 
administered via email and collected through Qualtrics online survey platform.  

Page 21 of 22
IRB LOG NUMBER: 16-
Page 21 of 22
Form Date: August 2016  Revision 6.0
භ
Provide significant new findings that may relate to the subjects willingness to continue to participate;
භ
Inform the IRB of any proposed changes in the research or informed consent process before changes are 
implemented, and agree that no changes will be made until approved by the KSU IRB (except where necessary to 
eliminate apparent immediate hazards to participants);
භ
Complete and submit a Continuing Review of Human Subjects Research application before the deadline for 
review at intervals determined by the IRB to be appropriate to the degree of risk (but not less than once per year) to 
avoid expiration of IRB approval and cessation of all research activities;
භ
Maintain research-related records (and source documents) in a manner that documents the validity of the 
research and integrity of the data collected, while protecting the confidentiality of the data and privacy of participants;
භ
Retain research-related records for audit for a period of at least three years after the research has ended (or 
longer, according to sponsor or publication requirements) even if I leave the University;
භ
Contact the Research Compliance for assistance in amending (to request a change in Principal Investigator) or 
terminating the research if I leave the University or am unavailable to conduct or supervise the research personally (e.g., 
sabbatical or extended leave);
භ
Provide a Final Study Report to the IRB when all research activities have ended (including data analysis with 
individually identifiable or coded private information); and
භ
Inform all Co-Investigators, research staff, employees, and students assisting in the conduct of the research of 
their obligations in meeting the above commitments.
Please type your name in the space below and send from your kent.edu email account.  verify that the information 
provided in this Use of Human Subjects in Research application is accurate and complete.
3/23/2018
Signature of Principal Investigator
Date
1. 
Sobell, M.B., et al., Developing a prototype for evaluating alcohol treatment effectiveness, in Evaluating 
alcohol and drug abuse treatment effectiveness: Recent advances, L.C. Sobell, M.B. Sobell, and E. Ward, 
Editors. 1980, Pergamon Press: New York. 
2. 
Greenwald, A.G., D.E. McGhee, and J.L. Schwartz, Measuring individual differences in implicit 
cognition: the implicit association test. J Pers Soc Psychol, 1998. 74(6): p. 1464-80. 
3. 
Houben, K. and R.W. Wiers, Response inhibition moderates the relationship between implicit 
associations and drinking behavior. Alcohol Clin Exp Res, 2009. 33(4): p. 626-33. 
4. 
Sheehan, D.V., et al., Reliability and validity of the mini international neuropsychiatric interview for 
children and adolescents (MINI-KID). The Journal of clinical psychiatry, 2010. 71(3): p. 313-326. 
5. 
Kuntsche, E. and S. Kuntsche, Development and Validation of the Drinking Motive Questionnaire 
Revised Short Form (DMQ–R SF). Journal of Clinical Child & Adolescent Psychology, 2009. 38(6): p. 899-
908. 
6. 
Stein, L.A.R., et al., Validity and Reliability of the Alcohol Expectancy Questionnaire-Adolescent, Brief.
Journal of child & adolescent substance abuse, 2007. 16(2): p. 115-127. 
7. 
Hogue, A., S. Dauber, and J. Morgenstern, Validation of a Contemplation Ladder in an Adult Substance 
Use Disorder Sample. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive 
Behaviors, 2010. 24(1): p. 137-144. 
8. 
Kramer, J.H., et al., NIH EXAMINER: conceptualization and development of an executive function 
battery. Journal of the International Neuropsychological Society, 2014. 20(1): p. 11-19. 
9. 
Reynolds, B. and R. Schiffbauer, Measuring state changes in human delay discounting: an experiential 
discounting task. Behav Processes, 2004. 67(3): p. 343-56. 

Page 22 of 22
IRB LOG NUMBER: 16-
Page 22 of 22
Form Date: August 2016  Revision 6.0
10. 
MacKillop, J., et al., Delayed reward discounting and addictive behavior: a meta-analysis.
Psychopharmacology, 2011. 216(3): p. 305-321. 
11. 
Whiteside, S.P., et al., 9DOLGDWLRQRIWKH8336LPSXOVLYHEHKDYLRXUVFDOHDIRXUఆIDFWRUPRGHORI
impulsivity. European Journal of Personality, 2005. 19(7): p. 559-574. 
12. 
Watson, D., L.A. Clark, and A. Tellegen., Development and validation of brief measures of positive and 
negative affect: the PANAS scales. Journal of personality and social psychology, 1988. 54(6): p. 1063-1070. 
13. 
Radloff, L.S., The CES-D Scale: a self-report depression scale for research in the
general population, in Anonymous Applied Psychological Measurement. 1977, West Publishing Co.: New 
York, NY. p. 385-401. 
14. 
Nakonezny, P.A., et al., Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in 
adult outpatients with major depressive disorder. J Psychiatr Res, 2015. 65: p. 124-30. 
15. 
Spitzer, R.L., et al., A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern 
Med, 2006. 166(10): p. 1092-7. 
16. 
Cohen, J., A power primer. Psychological Bulletin, 1992. 112(1): p. 155-159. 
17. 
Faul, F., et al., Statistical power analyses using G* Power 3.1: Tests for correlation and regression 
analyses. Behavior research methods, 2009. 41(4): p. 1149-1160.